[HTML][HTML] Implications of physics, chemistry and biology for dosimetry calculations using theranostic pairs
Theranostics is an emerging paradigm that combines imaging and therapy in order to
personalize patient treatment. In nuclear medicine, this is achieved by using …
personalize patient treatment. In nuclear medicine, this is achieved by using …
Preclinical Evaluation of [64Cu]NOTA-CP01 as a PET Imaging Agent for Metastatic Esophageal Squamous Cell Carcinoma
T Peng, X Wang, Z Li, L Bi, J Gao, M Yang… - Molecular …, 2021 - ACS Publications
Targeting metastatic esophageal squamous cell carcinoma (ESCC) has been a challenge in
clinical practice. Emerging evidence demonstrates that CXC chemokine receptor 4 (CXCR4) …
clinical practice. Emerging evidence demonstrates that CXC chemokine receptor 4 (CXCR4) …
Development of a theranostic convergence bioradiopharmaceutical for immuno-PET based radioimmunotherapy of L1CAM in cholangiocarcinoma model
IH Song, MS Jeong, HJ Hong, JI Shin, YS Park… - Clinical Cancer …, 2019 - AACR
Purpose: Cholangiocarcinoma is a malignancy of bile duct with a poor prognosis.
Conventional chemotherapy and radiotherapy are generally ineffective, and surgical …
Conventional chemotherapy and radiotherapy are generally ineffective, and surgical …
Advances and challenges in immunoPET methodology
P Mohr, J Van Sluis, MN Lub-de Hooge… - Frontiers in Nuclear …, 2024 - frontiersin.org
Immuno-positron emission tomography (immunoPET) enables imaging of specific targets
that play a role in targeted therapy and immunotherapy, such as antigens on cell …
that play a role in targeted therapy and immunotherapy, such as antigens on cell …
[HTML][HTML] An abbreviated therapy-dosimetric equation for the companion diagnostic/therapeutic [64/67Cu]Cu-SARTATE
E Laffon, H de Clermont, R Marthan - EJNMMI research, 2021 - Springer
In a preclinical model of neuroblastoma, Dearling et al. recently demonstrated the potential
interest for a theranostic approach of [64/67Cu] Cu-SARTATE for the detection and treatment …
interest for a theranostic approach of [64/67Cu] Cu-SARTATE for the detection and treatment …
Estimation of Cumulative Activity of 177Lu-Cetuximab from a Single Diagnostic 64Cu-Cetuximab Scan
E Laffon, R Marthan - Cancer Biotherapy & Radiopharmaceuticals, 2022 - liebertpub.com
Background: This study aimed at investigating whether a single diagnostic 64Cu-cetuximab
scan might predict therapeutic 177Lu-cetuximab cumulative activity in a preclinical study …
scan might predict therapeutic 177Lu-cetuximab cumulative activity in a preclinical study …
Preclinical SPECT and SPECT-CT in oncology
Molecular imaging enables both spatial and temporal understanding of the complex biologic
systems underlying carcinogenesis and malignant spread. Single-photon emission …
systems underlying carcinogenesis and malignant spread. Single-photon emission …